The New Republic on MSN5h
The Supreme Court Could Reignite an HIV Crisis
The next chapter of the right-wing war on the Affordable Care Act involves a case that targets the preventative care that ...
HIV pioneers are aging faster than normal, prompting new approaches to care
But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...
Rolling Out2d
How new HIV prevention strategies are changing lives
Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...
New Report Shows Link Between Ending HIV And Upholding Human Rights
Here are some of the findings from UNAIDS' new report on HIV and human rights, and what they could mean for the fight against ...
HIV vaccine candidate activates crucial immune function
Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells ...
HIV in 2025: 'There Is Hope for the Future,' Say Disease Experts
Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
ABC 11 Raleigh NC on MSN18h
Duke researchers achieve breakthrough in HIV vaccine development
Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.
The American Journal of Managed Care23h
Patients With HIV May Have High Prevalence of Long COVID
Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was ...
Why are so many Indigenous Panamanians contracting HIV — and dying of AIDS?
The government provides HIV medicines free of charge. Yet in one Indigenous territory, cases and deaths are increasing at an ...
Medscape2d
Two-Drug HIV Regimen Matches Three-Drug Options in Long-Term Treatment Success
Among treatment-naive people with HIV, dolutegravir/lamivudine showed viral suppression comparable with those of other ...
Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV
CNBC’s Angelica Peebles and Gilead chairman and CEO Daniel O’Day join 'Squawk Box' to discuss the company's new HIV ...